Dr. Patrick Soon-Shiong

speaker
969 appearances 7 recordings 4 series first heard Nov 2024 last heard 9 Oct

Dr. Patrick Soon-Shiong’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
1 · Oct OctJan 26AprJulnow

Recordings per month over the last 12 months — 1 in all, peaking in Oct 2025 with 1.

Appearances

newest first · ▶ plays the moment
Response?
I don't care.
I almost fell off my chair.
We told you, they went on, years and years ago, they said, that you have to do another comparative trial against chemotherapies.
I said, that doesn't make any sense because chemotherapy kills exactly the cells.
And in fact, here's real-world data that shows that if you do chemotherapy, you actually don't have memory.
You may have a response, but you have no duration.
So ethically...
How do I tell the patient, you're going to go on one arm, and guess one arm could be chemotherapy, one arm is my drug, but I have to be honest with you that one arm is going to give you low lymphocyte count, and the other arm is going to give you freedom.
I wouldn't be able to even recruit that trial.
Response, I don't care.
Next response, this is how we've done this for years, and this is how we will continue to do it.
I walked out of the room completely devastated and wondered what was going on.
Three weeks later, I see in the press that Johnson & Johnson is about to get priority review by the agency for chemotherapy in the bladder.
Yes.
a month ago, and they just got it approved, priority review, for which, and you look at the package insert, there's a 1% mortality from the chemotherapy put into a pretzel-like device into the bladder, and a 24% low lymphocyte count.
But it got priority review.
When we filed our drug in 2021,
three, 20, 22, even though that breakthrough status, they refused priority review.
Now, why is this discrepancy?
Showing 381–400 of 969 · page 20 of 49 ← Previous Next →